QuickView for DNA topoisomerase II activity (biogroup)

1. Multiple cancer cell lines treated with 32 kinase inhibitors
2. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
3. Diffuse large B-cell lymphoma HLY1 cells overexpressing elF4E1 or eIF4E3
4. L1000 CMAP - Embryonic kidney 293T cells with shRNA-mediated gene knockdown
5. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens

There were no matches for DNA topoisomerase II activity

1. Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubic…
2. Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast …
3. Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
4. Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
5. A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide